Researcher
Marc BUYSE
- Keywords:Mathematics
- Disciplines:Other mathematical sciences and statistics not elsewhere classified
Affiliations
- Data Science Institute (Research institute)
Member
From1 Jun 2019 → Today - Mathematics and statistics (Department)
Member
From1 Jan 2013 → Today - Centre for Statistics (Research group)
Member
From1 Jan 1994 → Today - Faculty of Sciences (Faculty)
Member
From1 Oct 1991 → Today - Applied Mathematics (Department)
Member
From1 Oct 2001 → 31 Dec 2012 - Research Institute Center for Statistics (Research institute)
Member
From1 Oct 1994 → 31 May 2019 - Mathematics-Physics-Informatics (Division)
Member
From1 Oct 1991 → 30 Sep 2009
Publications
11 - 20 of 109
- The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustration(2022)
Authors: Corinne Jamoul, Laurence Collette, Elisabeth Coart, Koenraad D'Hollander, Tomasz BURZYKOWSKI, Everardo D Saad, Marc BUYSE
- Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator Outcomes(2022)
Authors: Sylviane de Viron, Laura Trotta, William Steijn, Steve Young, Marc BUYSE
Pages: 295 - 303 - Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology(2022)
Authors: Richard M. Goldberg, Richard Adams, Marc BUYSE, Cathy Eng, Axel Grothey, Thierry Andre, Alberto F. Sobrero, Stuart M. Lichtman, Al B. Benson, Cornelis J. A. Punt, et al.
Pages: 819 - 828 - On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes(2022)
Authors: Mickael De Backer, Catherine LEGRAND, Julien Peron, Alexandre Lambert, Marc BUYSE
Pages: 284 - 299 - Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring(2022)
Authors: Sylviane de Viron, Laura Trotta, Helmut Schumacher, Hans-Juergen Lomp, Sebastiaan Hoppner, Steve Young, Marc BUYSE
Pages: 130 - 136 - Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpoint(2022)
Authors: Leandro Garcia Barrado, Tomasz BURZYKOWSKI, Catherine LEGRAND, Marc BUYSE
Pages: 209 - 219 - Correcting the bias of the net benefit estimator due to right-censored observations(2021)
Authors: Julien Peron, Maryam Idlhaj, Delphine Maucort-Boulch, Joris Giai, Pascal Roy, Laurence Collette, Marc BUYSE, Brice Ozenne
Pages: 893 - 906 - Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation study(2021)
Authors: Joris Giai, Delphine Maucort-Boulch, Brice Ozenne, Jean-Christophe Chiem, Marc BUYSE, Julien Peron
Pages: 553 - 565 - International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer(2021)
Authors: Emmanouil Fokas, Ane Appelt, Robert Glynne-Jones, Geerard Beets, Rodrigo Perez, Julio Garcia-Aguilar, Eric Rullier, J. Joshua Smith, Corrie Marijnen, Femke P. Peters, et al.
- The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research(2021)
Authors: P Ranganathan, G Chinnaswamy, M Sengar, D Gadgil, S Thiagarajan, B Bhargava, CM Booth, Marc BUYSE, S Chopra, C Frampton, et al.
Pages: E369 - E376